According to two people familiar with the matter, Dr. Moncef Sloughey, the chief adviser of “Move Fast”, submitted a resignation report at the request of the upcoming Biden team. Under this plan, he will continue to serve for one month to assist in the transition. .
People familiar with the matter said that after January 20, Sloughey’s role in leading the development of vaccines in the government’s unprecedented efforts will be weakened. It will end on February 1
It is not clear who after that will be led by the Biden team focused on the scientific leadership of the Covid vaccine, or whether someone will be appointed to that role. In the United States, two vaccines have been approved, and there are three more in late-stage clinical trials. Jeff Zients is the coordinator of Biden’s Covid-19 response, and Bechara Choucair will be the coordinator of the Covid-19 vaccine, working to accelerate the delivery of the vaccine.
One of the people familiar with the matter said that Slloy’s current contract includes a 30-day notice before the termination of the contract, and the Biden team did not require Slloy to continue to comply.
GlaxoSmithKline pharmaceutical executive Moncef Slaoui will serve as President Donald Trump’s speech at the Coronavirus disease response event held in White Gardens, and will serve as the search for coronavirus disease (COVID-19) Lead consultant for pandemic vaccine. House in Washington.
Kevin Lamake | Reuters
Slaoui had previously stated that he planned to resign after two vaccines and two therapies for Covid-19 entered the market, which happened last month because of the removal of the Moderna vaccine. He said last week that he “decided to expand this scope to ensure that the operation continues in the way it was implemented during the transitional administration.” But he pointed out that “we are approaching the point where my value-added is more restricted.”
Although the initial vaccine launch was criticized, the speed of vaccine development overseen by Slaoui has exceeded expectations: Pfizer and Moderna have approved two vaccines in the United States with 95% efficacy in preventing diseases. Johnson & Johnson’s key results on its vaccines are expected to be completed within a few weeks. This is the fastest vaccine development ever.
When Slaoui took office, he was criticized for his relationship with the pharmaceutical industry. While announcing his position, he resigned from Moderna’s board of directors. He sold his shares in the company and said that he had donated their value-added stock during the days when he was at the helm of “Operation Speed”.
However, he refused to sell his shares in GlaxoSmithKline, where he spent 30 years overseeing vaccine development, calling the shares his retirement.
He was particularly criticized by Senator Elizabeth Warren and responded to her in a video in September, saying that he was a registered Democrat, but he “had no hesitation” and acted “because This epidemic is bigger than any of us.”
Slaoui was paid $1,000 for overseeing the work of “Operation Distortion Speed,” and he said he plans to donate to scientific research.